AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

RIT Capital Partners PLC

AGM Information Apr 26, 2018

4696_rns_2018-04-26_eae1972f-1ba2-431c-9e81-a5a80af44230.html

AGM Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2611M

RIT Capital Partners PLC

26 April 2018

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

26 April 2018

Election of Directors

Following the passing of all resolutions by shareholders at its Annual General Meeting, RIT Capital Partners plc ('RIT') announces the following elections to the Board with immediate effect:

André Perold

André Perold has been elected to the Board as a Non-Executive Director.  Mr Perold is a Co-Founder, Managing Partner and Chief Investment Officer of HighVista Strategies, a Boston based investment firm. He is a board member of the Vanguard Group, the global investment company and also serves on the Investment Committee of the Partners Healthcare System.

Mr Perold will sit on the Audit & Risk Committee.

There are no other details that require to be disclosed in respect of the appointment of Mr Perold  pursuant to Rule 9.6.13 of the UK Listing Rules.

Jeremy Sillem

Jeremy Sillem has been elected to the Board as a Non-Executive Director.    Mr Sillem is Managing Partner and Founder of Spencer House Partners LLP, which provides corporate finance advice to asset and wealth management businesses. From 2000 to 2004 he was Executive Chairman of Bear Stearns International in London, prior to which he had a 28-year career with Lazard in London and New York.

Mr Sillem will sit on the Audit & Risk Committee.

Mr Sillem is currently a director of Biopharma Credit PLC.  There are no other details that require to be disclosed in respect of the appointment of Mr Sillem pursuant to Rule 9.6.13 of the UK Listing Rules.

Composition of Board Committee

Phillipe Costeletos has been appointed as a member of the Remuneration Committee of RIT, with immediate effect.

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAFQLFLVZFZBBB

Talk to a Data Expert

Have a question? We'll get back to you promptly.